Targeting Cancer with Genetically Engineered TCR T Cells
Author:
Publisher
Springer International Publishing
Link
http://link.springer.com/content/pdf/10.1007/978-3-030-23765-3_4
Reference144 articles.
1. Alexander-Miller MA, Leggatt GR, Berzofsky JA (1996) Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy. Proc Natl Acad Sci U S A 93(9):4102–4107. PubMed PMID: 8633023. Pubmed Central PMCID: 39494
2. Baier PK, Wimmenauer S, Hirsch T, von Specht BU, von Kleist S, Keller H et al (1998) Analysis of the T cell receptor variability of tumor-infiltrating lymphocytes in colorectal carcinomas. Tumour Biol 19(3):205-212. PubMed PMID: 9591047
3. Barth RJ Jr, Mule JJ, Spiess PJ, Rosenberg SA (1991) Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes. J Exp Med 173(3):647–658. PubMed PMID: 1900079. Pubmed Central PMCID: 2118834
4. Bendle GM, Linnemann C, Hooijkaas AI, Bies L, de Witte MA, Jorritsma A et al (2010) Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy. Nat Med 16(5):565–570
5. Benlalam H, Vignard V, Khammari A, Bonnin A, Godet Y, Pandolfino MC et al (2007) Infusion of Melan-A/Mart-1 specific tumor-infiltrating lymphocytes enhanced relapse-free survival of melanoma patients. Cancer Immunol Immunother 56(4):515–526. PubMed PMID: 16874485
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A Novel Cell-based Luciferase Reporter Platform for the Development and Characterization of T-Cell Redirecting Therapies and Vaccine Development;Journal of Immunotherapy;2023-02-20
2. Neoantigen-targeted TCR-T cell therapy for solid tumors: How far from clinical application;Cancer Letters;2022-10
3. Emerging immune-based technologies for high-grade gliomas;Expert Review of Anticancer Therapy;2022-08-12
4. Application of Genome-Editing Technologies for Off-the-Shelf T Cell-Based Cancer Immunotherapy;Precision Medicine and Clinical OMICS;2021-07-18
5. Against the Resilience of High-Grade Gliomas: The Immunotherapeutic Approach (Part I);Brain Sciences;2021-03-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3